All publications of “Fábio Sândoli de Brito Júnior”

2 results

Safety and efficacy of biolimus-eluting stent with biodegradable polymer: insights from EINSTEIN (Evaluation of Next-generation drug-eluting STEnt IN patients with coronary artery disease) Registry

Cristiano Freitas de Souza, Anwar Mohamed El Mouallem, Fábio Sândoli de Brito Júnior, Alexandre Antônio Cunha Abizaid, Breno Oliveira Almeida, Amanda Gonçalves Almeida, [...]

DOI: 10.1590/S1679-45082013000300015

Objective:To evaluate the incidence of major adverse cardiac events (cardiac death, or acute myocardial infarct, or target vessel revascularization) at one year in “real world” patients.METHODS:The EINSTEIN registry is an observational, prospective, single center study that consecutively included 103 patients (152 lesions) treated with the BiomatrixTM stent, a biolimus A9-eluting stent with biodegradable polymer.RESULTS:The mean age was 65.0±12.4 years; male gender represented 83.5% of the patients; and 37.9% of them were diabetic. At one-year, major adverse cardiac events occurred in […]

Effect of implementing an acute myocardial infarction guideline on quality indicators

Marcia Makdisse, Marcelo Katz, Alessandra da Graça Corrêa, Luciano Monte Alegre Forlenza, Marco Antonio Perin, Fábio Sândoli de Brito Júnior, [...]

DOI: 10.1590/S1679-45082013000300016

Objective:To evaluate the compliance rates to quality of care indicators along the implementation of an acute myocardial infarction clinical practice guideline.METHODS:A clinical guideline for acute myocardial infarction was introduced on March 1st, 2005. Patients admitted for acute myocardial infarction from March 1st, 2005 to December 31st, 2012 (n=1,431) were compared to patients admitted for acute myocardial infarction before the implementation of the protocol (n=306). Compliance rates to quality of care indicators (ASA prescription on hospital admission and discharge, betablockers on […]